A type of 510(k) used when FDA agrees that the risk of the product is appropriate for Class II but there is not a predicate device. This mechanism may only be used if there is an agreement in place with the Agency prior to submission of the 510(k).
de novo 510(k)
Share / Follow
Recent Blogs
Great New Companion Diagnostics E-Book Released Today
A valuable resource in a hot, but under-informed segment of the market
Oragene Clearance Shows DNA Stabilization is Class II
Clearance could have a significant impact on DTCG providers
My Screening Test for Screening Tests
Offering up a rare bit of regulatory certainty
The Abolish OIVD Act of 2011
A torches-and-pitchforks approach to LDT regulations